19 July 2022 in npj Parkinson's Disease
Leucine-rich repeat kinase 2 (LRRK2) is a kinase involved in different cellular functions, including autophagy, endolysosomal pathways, and immune function. Mutations in LRRK2 cause autosomal-dominant forms of Parkinson’s disease (PD). Heterozygous mutations in GBA1, the gene encoding the lysosomal enzyme glucocerebrosidase (GCase), are the most common genetic risk factors for PD. Moreover, GCase function is altered in idiopathic PD and in other genetic forms of the disease. Recent work suggests that LRRK2 kinase activity can regulate GCase function. However, both a positive and a negative correlation have been described. To gain insights into the impact of LRRK2 on GCase, we performed a comprehensive analysis of GCase levels and activity in complementary LRRK2 models, including (i) LRRK2 G2019S knock in (GSKI) mice, (ii) peripheral blood mononuclear cell (PBMCs), plasma, and fibroblasts from PD patients carrying LRRK2 G2019S mutation, (iii) patient iPSCs-derived neurons; (iv) endogenous and overexpressed cell models. In some of these models we found a positive correlation between the activities of LRRK2 and GCase, which was further confirmed in cell lines with genetic and pharmacological manipulation of LRRK2 kinase activity. GCase protein level is reduced in GSKI brain tissues and in G2019S iPSCs-derived neurons, but increased in fibroblasts and PBMCs from patients, suggesting cell-type-specific effects. Overall, our study indicates that LRRK2 kinase activity affects both the levels and the catalytic activity of GCase in a cell-type-specific manner, with important implications in the context of therapeutic application of LRRK2 inhibitors in GBA1-linked and idiopathic PD.
8 June 2022 in npj Parkinson's Disease
LPLilian Petropoulou-Vathi
PVPolitymi-Eleni Valkimadi
LDLampros Dimitrakopoulos
+5
Despite several advances in the field, pharmacodynamic outcome measures reflective of LRRK2 kinase activity in clinical biofluids remain urgently needed. A variety of targets and approaches have been utilized including assessments of LRRK2 itself (levels, phosphorylation), or its substrates (e.g. Rab10 or other Rab GTPases). We have previously shown that intrinsic kinase activity of LRRK2 isolated from PBMCs of G2019S carriers is elevated, irrespective of disease status. In the present study we find that phosphorylation of Rab10 is also elevated in G2019S carriers, but only those with PD. Additionally, phosphorylation of this substrate is also elevated in two separate idiopathic PD cohorts, but not in carriers of the A53T mutation in α-synuclein. In contrast, Rab29 phosphorylation was specifically reduced in urinary exosomes from A53T and idiopathic PD patients. Taken together, our findings highlight the need for the assessment of multiple complimentary targets for a more comprehensive picture of the disease.
2 March 2026 in Hellenic Journal of Cardiology
Despite increasing female participation in medicine, gender disparities persist in cardiology and cardiac surgery globally. In Greece, data on gender disparities in these specialties have been limited. To systematically investigate the professional experiences, perceived barriers, and career development challenges faced by women cardiologists and cardiac surgeons in Greece. A national, cross-sectional survey was distributed electronically to all female members of the Hellenic Society of Cardiology and the Hellenic Society of Thoracic and Cardiovascular Surgeons. The 47-item questionnaire captured demographic, academic, and professional data, including perceptions of gender-related bias, leadership representation, and work-life integration. Among 743 recipients, 243 women responded (response rate: 33%). Although 47% held an MSc, 39% a PhD, and over 55% a subspecialization, only 3.8% occupied academic positions. Most participants reported placing their careers secondary to maternal responsibilities (78%) and considered their gender a barrier to career progression (64.7%). Gender-based discrimination and workplace bullying were reported by 58.7%, and 49.6% indicated patient mistrust. Only 27.5% believed they had equal career advancement opportunities, and just 21.2% felt equally represented in research leadership. Representation in national scientific societies and academic leadership remains markedly low, consistent with European data showing only a few female heads of cardiology departments in Greece. Women cardiologists and cardiac surgeons in Greece face multifaceted and deeply entrenched structural barriers despite high levels of qualification. These findings call for urgent policy, institutional, and cultural reforms to advance gender equity in cardiovascular medicine and surgery.